long-awaited reversal brought MRNA to previous highs.
I expect it to go the green way, reaching 220’s-240’s, after which the profit-taking spree will bring it back to 180’s or lower.
much, of course, will depend on the earnings in 2 days.
if the earnings are exceptionally great, it may take the grey way, with potential ATH just shy of 300.
and if they upset, we...
I am not a fan of TSLA, I (have always :)) considered it extremely overvalued, and it still may be the case.
However it looks like a buying opportunity.
First, 500 was a resistance.
Then second time resistance, and turned into support.
Will it stand this level this time?
RSI is 26.8, and it was lower only during the first covid drop last year.
It was lower...
VIR has a couple of interesting products testing in the pipeline.
The one that caused the spike in Jan is for hepatitis B treatment.
And the selloff today is caused by the pause in the enrollment of late-stage trial testing of their Covid19 antibody.
So it seems it is safe to assume that it will return above previous resistance of 53. With 80's as a first target,...
COGT has been trading in the range during 7 months.
Being close to the support it gives an opportunity to buy it with a tight stop-loss just below the support level.
1) 40-50% if bought close to the support at 8.40 and sold as close as possible to resistance at 13.28.
But I would not bet on buying cheaper than 9.00 as it is where it meets MA200,...
If you want to short Bitcoin, this is one of the options - inverse Bitcoin ETP on SIX Swiss Exchange.
I will not discuss here why would you and whether you should, this is just to outline the possibility.
And as a final note - I am buying some.
IMUX has been trading in the channel for over 6 months.
Now it seems it is trying to break it.
If it stands the support at 20.20 (used to be resistance), it may look like a good BUY signal.
Alternatively, can try to wait if it drops back to the support at 15.00.
I think I will give it a try now.
MRNA could possibly reach as high as 250’s before or after the earnings report on 10 Mar.
Not only it may beat the earnings estimate, there are also quite positive news which may lead to explosive growth.
First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research
NEW YORK and LA JOLLA, CA—A phase 1 clinical trial...
"When Tesla CEO Elon Musk urged his Twitter followers on Thursday to “use Signal,” he meant the encrypted messaging app. Some people appear to have taken it the wrong way.
Shares of an obscure and unrelated company called Signal Advance, which trades over the counter, surged 527% on Thursday and another 91% on Friday, climbing from 60 cents to $7.19."
What used to be a resistance now a support.
Plus an inverse head & shoulders.
Plus positive news: “Supernus said that a Phase 3 trial 'met the primary endpoint ... compared to placebo in improving the symptoms of ADHD.'"
Going long anticipating 30’s where MA200 is and then maybe higher.
With tight stop-loss just behind the support.
Carmat SA, producer of first ever artificial heart, obtained permission to sell it in the EU as a bridge to a heart transplant.
It also pans to treat the first patients in the US in the first quarter 2021 “based on ongoing discussions with the FDA”.
In the EU only estimated annual sales may amount to 700 million EUR by 2030.
Thus, I expect market cap to increase...
These are results of 2020.
Actually, these are 1 month results, as I have just started here in the end of November 2020.
Total ideas: 24
Ideas that won and closed with profit: 7 (5 exactly as predicted, 2 closed earlier with smaller profit)
Lost on predicting movement: 7
Active trades that are moving in favorable direction: 7
Unclear active trades that still...